2019
DOI: 10.22159/ijcpr.2019v11i4.34937
|View full text |Cite
|
Sign up to set email alerts
|

Development and Validation of Uv-Visible Spectrophotometric Method for Analysis of Bosentan in Spiked Human Plasma

Abstract: Objective:The aim of the present study is to develop and validate a simple, efficient, economical and accurate UV-visible spectrophotometric method for estimation of bosentan in spiked human plasma. Methods:The analyte was extracted by Liquid-liquid Extraction (LLE) procedure using acetonitrile and chloroform. Absorbance of the analyte in the extract was measured at 270 nm using ethanol as a diluent. The developed method was validated for linearity, accuracy and robustness. Results:The proposed method was foun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Bosentan's affinity for ETA receptors is somewhat greater than for ETB receptors 3 . The amount of Bosentan in biological samples has been estimated using methods such as gradient Reverse Phase-High Performance Liquid Chromatography (RP-HPLC), Solid Phase Extraction Liquid Chromatography-tandem Mass Spectrometry (SPE-LC-MS/ MS), and UV-visible spectrophotometric methods, which are costly and challenging to implement [4][5][6][7][8] .…”
Section: Introductionmentioning
confidence: 99%
“…Bosentan's affinity for ETA receptors is somewhat greater than for ETB receptors 3 . The amount of Bosentan in biological samples has been estimated using methods such as gradient Reverse Phase-High Performance Liquid Chromatography (RP-HPLC), Solid Phase Extraction Liquid Chromatography-tandem Mass Spectrometry (SPE-LC-MS/ MS), and UV-visible spectrophotometric methods, which are costly and challenging to implement [4][5][6][7][8] .…”
Section: Introductionmentioning
confidence: 99%